-- 据《澳大利亚金融评论报》周一援引Global X ETFs的数据报道，CSL（ASX:CSL）领跌澳大利亚股市，今年迄今为止市值损失高达232亿澳元，ResMed（ASX:RMD）和Cochlear（ASX:COH）紧随其后，市值损失均为106亿澳元。 Global X ETFs高级产品及投资策略师Marc Jocum表示，S&P/ASX 200指数中表现不佳的公司累计市值蒸发超过2170亿澳元。 （市场动态新闻来源于与全球市场专业人士的对话。这些信息被认为来自可靠来源，但可能包含传闻和推测。准确性无法保证。）
Related Articles
Asia
Market Chatter: Coles CEO Says Grocery Price Increases 'Inevitable' Amid Fuel Cost Surge
Coles Group (ASX:COL) Chief Executive Leah Weckert said price hikes for groceries are "inevitable" as the supermarket chain and its suppliers deal with higher fuel costs, Bloomberg reported Monday.Speaking at an Australian Shareholders' Association conference in Melbourne, Weckert said that the trend is showing up in supermarket data, with shoppers opting for beef mince or chicken over steak, while also making fewer trips to stores to cut fuel costs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:COL
Asia
Singapore Airlines to Deploy Starlink Broadband Services in 2027
Singapore Airlines (SGX:C6L) will deploy Starlink's low-earth-orbit satellite-based broadband service on its planes, starting from the first quarter of 2027, according to a company release on Monday.The service will be available to all cabin classes on Starlink-enabled aircraft.
$SGX:C6L
Asia
iX Biopharma Secures Listing and Quotation Notice for New Shares; Shares Zoom 11%
iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.
$SGX:42C